March 7, 2012 |
Many women who used estrogen alone as hormone replacement therapy after menopause had a lower risk of developing breast cancer up to five years after they stopped taking it, a study has found. The research, published Tuesday, adds another twist to the evolving story on whether hormone replacement therapy helps some women beyond treating menopausal symptoms such as hot flashes and poor sleep quality. The report is a follow-up analysis of the landmark Women's Health Initiative, a clinical trial of tens of thousands of women begun in 1993 that sought to clarify the risks and benefits of two hormone replacement therapy regimens in postmenopausal women: estrogen plus progestin, which most women must take, and estrogen alone, taken by women who have had hysterectomies.
June 6, 2011 |
Flaxseed is widely believed to reduce the incidence and severity of hot flashes, both those resulting from menopause and those caused by estrogen-deprivation therapies in the treatment of breast cancer. But a new clinical trial has found that daily consumption of flaxseed is no more effective than a placebo in blocking symptoms, researchers reported Sunday at a Chicago meeting of the American Society of ClinicalOncology. The results were "surprising," lead author Sandhya Pruthi of the Mayo clinic in Rochester, Minn., said, because a preliminary trial she conducted appeared to show benefit.
April 14, 2011 |
Changes in a woman's body may occur throughout the month, but the tone of her voice might not be one of them. New research presented this week at the Experimental Biology meeting in Washington, D.C., challenges previous studies indicating there were detectable variations in a woman's voice at various times over her menstrual cycle that could be linked to hormone levels. Researchers from West Texas A&M University in Canyon analyzed 175 voice samples from 35 women that were recorded at four times during two cycles: the menstrual phase (estrogen and progesterone levels are low)
April 5, 2011 |
Although many women have sworn off hormone therapy, a new analysis from the clinical trial that first unearthed the hormones' risks shows taking estrogen alone for menopausal symptoms, even for several years, may be safer than first thought. The new finding — the latest from the Women's Health Initiative, a federally funded trial that tracked thousands of women taking hormones or placebo pills for years — looked at women who have had hysterectomies and thus can take estrogen unaccompanied by another hormone, progestin.
December 9, 2010 |
Estrogen-only hormone replacement therapy may benefit younger postmenopausal women who do not have a uterus, a Canadian researcher said Thursday at the annual meeting of the San Antonio Breast Cancer Symposium. Dr. Joseph Ragaz, an oncologist at the University of British Columbia, presented a re-analysis of the Women's Health Initiative -- which originally concluded that both long-term estrogen-only and estrogen-plus-progestin hormone replacement were too risky for most women.
July 29, 2010
The Food and Drug Administration on Thursday warned menopausal women using Evamist to avoid allowing children and pets to come into contact with the drug. Evamist contains the estrogen hormone estradiol and is sprayed on the forearms between the elbow and wrist to reduce hot flashes. The FDA said it has received eight reports of adverse effects from exposure to the drug in children ages 3 to 5, and two reports of problems with pets. Young girls who came into contact with the drug reported symptoms of premature puberty, including development of breast buds and breast mass.
July 12, 2010 |
More than 100,000 women each year are diagnosed with a type of breast cancer called postmenopausal estrogen receptor-positive -- the most common type of breast cancer. Studies in recent years have shown that an important tool to prevent recurrence of this type of breast cancer lies in the use of medications called aromatase inhibitors. On Monday, cancer experts issued guidelines updating the knowledge about aromatase inhibitors -- which are medications that lower estrogen -- and how women and their doctors should best utilize this class of drugs.
December 9, 2009 |
Soy foods do not appear to increase the risk of breast cancer recurrence among survivors of the disease and may even confer some health benefits, new research suggests. The study, published in today's issue of the Journal of the American Medical Assn., should reassure breast cancer survivors that they need not scrupulously avoid soy foods, which have become increasingly popular in the United States in recent years. Research in animals has indicated that soy might increase the chances of breast cancer recurrence because it can act like the hormone estrogen, which promotes tumor growth.
July 6, 2009 |
I am a breast-cancer survivor and have heard that some sunscreens contain estrogen-like compounds. I cannot have anything that contains estrogen in or on my body. I would like to know which brands to avoid which are safe. Benzophenone-3 (BP-3 or oxybenzone) has estrogen-like activity. Try sunscreen with physical blockers such as titanium dioxide or zinc oxide. :: My husband has COPD (chronic obstructive pulmonary disease) and suffers when he retains water.
August 9, 2008 |
Estrogen may ease the symptoms of schizophrenia in women with severe disease, Australian researchers reported Tuesday in the Archives of General Psychiatry. Researchers started focusing on estrogen's links to schizophrenia about two decades ago when it became clear that female patients typically fell ill an average of about five years after males. Symptoms in women also tend to worsen after childbirth and menopause, when estrogen levels are lower, and ease during menstruation and pregnancy, when hormone levels are high.